MetaBank Provides Tax Season Update
Mar 07, 2017 22:05 pm UTC| Business
SIOUX FALLS, S.D., March 07, 2017 -- Meta Financial Group, Inc.® (Nasdaq:CASH) (the “Company”) announced today preliminary 2017 tax season results at its bank subsidiary, MetaBank®. From December 12, 2016 through...
Fibrocell Announces Convertible Preferred Stock Financing for $8.0 Million
Mar 07, 2017 21:54 pm UTC| Business
EXTON, Pa., March 07, 2017 -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that it...
Mar 07, 2017 21:50 pm UTC| Business
FORT WORTH, Texas, March 07, 2017 -- Tandy Leather Factory, Inc. (NASDAQ:TLF) announced today that it will be presenting at the 29th Annual ROTHInvestor Conference on Wednesday, March 15, 2017 at the Ritz Carlton in...
Team, Inc. Reports Fourth Quarter and Full Year 2016 Results
Mar 07, 2017 21:48 pm UTC| Business
SUGAR LAND, Texas, March 07, 2017 -- Team, Inc. (NYSE:TISI) (“Team,” “we,” “our,” or the “Company”) today reported its financial results for the fourth quarter and full year ended December 31, 2016. Team reported a net...
Globalstar Announces Appointment of Kyle Pickens as Vice President of Strategy and Communications
Mar 07, 2017 21:48 pm UTC| Business
COVINGTON, La., March 07, 2017 -- Globalstar, Inc.(NYSE:GSAT) today announced that Kyle Pickens has been appointed as Vice President of Strategy and Communications. Mr. Pickens will be responsible for the overall...
Platform Specialty Products Corporation to Present at the 29th Annual ROTH Conference
Mar 07, 2017 21:45 pm UTC| Business
WEST PALM BEACH, Fla., March 07, 2017 -- Platform Specialty Products Corporation (NYSE:PAH)(“Platform”), a global specialty chemicals company, announced today that Benjamin Gliklich, Executive Vice President –...
Mar 07, 2017 21:35 pm UTC| Business
Interim analysis results from two Phase 3 trials of AXS-02 in separate indications anticipated in 2H 2017 Top-line results from the Phase 3 STRIDE-1 trial of AXS-05 in treatment resistant depression expected in 1Q 2018 ...